Seroprevalence of chronic hepatitis B virus infection among Taiwanese human immunodeficiency virus type 1-positive persons in the era of nationwide hepatitis B vaccination

American Journal of Gastroenterology

Volumn 104, Issue 4, 2009, Pages 877-884

  Sun, Hsin Yun ^a   Ko, Wen Chien ^b   Tsai, Jih Jin ^c   Lee, Hsin Chun ^b   Liu, Chun Eng ^d   Wong, Wing Wai ^e   Su, Shey Chiang ^f   Ho, Mao Wang ^g   Cheng, Shu Hsing ^h   Yang, Chin Hui ⁱ   Lin, Yu Hui ^j   Miao, Wei Jay ^k   Sheng, Wang Huei ^a   Hung, Chien Ching ^a  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^b NATIONAL CHENG KUNG UNIVERSITY HOSPITAL   (Taiwan)

^c KAOHSIUNG MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^d CHANGHUA CHRISTIAN HOSPITAL   (Taiwan)

^e TAIPEI CITY HOSPITAL   (Taiwan)

^f MACKAY MEMORIAL HOSPITAL   (Taiwan)

^g CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^h Taoyuan Hospital   (Taiwan)

ⁱ CENTER FOR DISEASE CONTROL   (Taiwan)

^j TAICHUNG VETERANS GENERAL HOSPITAL   (Taiwan)

^k MENNONITE CHRISTIAN HOSPITAL   (Taiwan)

more..

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS B ANTIBODY; HEPATITIS B CORE ANTIBODY; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B VACCINE; HEPATITIS C ANTIBODY; HUMAN IMMUNODEFICIENCY VIRUS ANTIBODY;

ADOLESCENT; ADULT; AGED; ARTICLE; CHILDHOOD; CHRONIC HEPATITIS; COMPARATIVE STUDY; CONTROLLED STUDY; FEMALE; HEPATITIS B; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; MAJOR CLINICAL STUDY; MALE; PERINATAL PERIOD; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SEROPREVALENCE; TAIWAN; VACCINATION; AIDS-RELATED OPPORTUNISTIC INFECTIONS; CONFIDENCE INTERVAL; HEPATITIS B VIRUS; HEPATITIS B, CHRONIC; HIV SEROPOSITIVITY; IMMUNOLOGY; INCIDENCE; MIDDLE AGED; PROCEDURES; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; AIDS-RELATED OPPORTUNISTIC INFECTIONS; CONFIDENCE INTERVALS; FEMALE; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VACCINES; HEPATITIS B VIRUS; HEPATITIS B, CHRONIC; HIV ANTIBODIES; HIV SEROPOSITIVITY; HIV-1; HUMANS; INCIDENCE; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; SEROEPIDEMIOLOGIC STUDIES; TAIWAN; VACCINATION; YOUNG ADULT;

EID: 65449153663     PISSN: 00029270     EISSN: 15720241     Source Type: Journal    
DOI: 10.1038/ajg.2008.159     Document Type: Article

References (37)

1. Konopnicki D, MocroD A, de Wit S et al. Hepatitis B and HIV: prevalence, AIDS progression, response to highly active antiretroviral therapy and increased mortality in the EuroSIDA cohort. AIDS 2005;19:593-601.
2. Kellerman SE, Hanson DL, McNaghten AD et al. Prevalence of chronic hepatitis B and incidence of acute hepatitis B infection in human immunodeficiency virus-infected subjects. J Infect Dis 2003;188:571-7.
3. Hoffmann CJ, E io CL. Clinical implications of HIV and hepatitis B co-infection in Asia and Africa. Lancet Infect Dis 2007;7:402-9.
4. de Lalla F, Rizzardini G, Rinaldi E et al. HIV, HBV, delta-agent and Treponema pallidum infections in two rural African areas. Trans R Soc Trop Med Hyg 1990;84:144-7.
5. Shao FJ, Haukenes G, Yangi E et al. Association of hepatitis B and human immunodeI ciency virus infections in Tanzanian population groups. Eur J Clin Microbiol Infect Dis 1993;12:62-4.
6. Menendez C, Sanchez-Tapias JM, Kahigwa E et al. Prevalence and mother-to-infant transmission of hepatitis viruses B, C, and E in Southern Tanzania. J Med Virol 1999;58:215-20.
7. Rouet F, Chaix ML, Inwoley A et al. HBV and HCV prevalence and viraemia in HIV-positive and HIV-negative pregnant women in Abidjan, Cote d ' Ivoire: the ANRS 1236 study. J Med Virol 2004;74:34-40.
8. Sutclife S, Taha TE, Kumwenda NI et al. HIV-1 prevalence and herpes simplex virus 2, hepatitis C virus, and hepatitis B virus infections among male workers at a sugar estate in Malawi. J Acquir Immune Defic Syndr 2002;31:90-7.
9. Matee MI, Magesa PM, Lyamuya EF. Seroprevalence of human immunodeficiency virus, hepatitis B and C viruses and syphilis infections among blood donors at the Muhimbili National Hospital in Dar es Salaam, Tanzania. BMC Public Health 2006;6:21.
10. Palella FJ Jr, Delaney KM, Moorman AC et al. Declining morbidity and mortality among patients with advanced human immunodeI ciency virus infection. HIV Outpatient Study Investigators. N Engl J Med 1998;338:853-60.
11. MocroD A, Ledergerber B, Katlama C et al. Decline in the AIDS and death rates in the EuroSIDA study: an observational study. Lancet 2003;362:22-9.
12. Sheng WH, Chen MY, Hsieh SM et al. Impact of chronic hepatitis B virus (HBV) infection on outcomes of patients infected with HIV in an area where HBV infection is hyperendemic. Clin Infect Dis 2004;38:1471-7.
13. Weber R, Sabin CA, Friis-Moller N et al. Liver-related deaths in persons infected with the human immunodeI ciency virus: the D:A:D study. Arch Intern Med 2006;166:1632-14.
14. Advisory Committee on Immunization Practices. Recommended adult immunization schedule: United States, October 2007-September 2008. Ann Intern Med 2007;147:725-9.
15. Carne CA, Weller IV, Waite J et al. Impaired responsiveness of homosexual men with HIV antibodies to plasma derived hepatitis B vaccine. Br Med J (Clin Res Ed) 1987;294:866-8.
16. Odaka N, Eldred L, Cohn S et al. Comparative immunogenicity of plasma and recombinant hepatitis B virus vaccines in homosexual men. JAMA 1988;260:3635-7.
17. Collier AC, Corey L, Murphy VL et al. Antibody to human immunode I ciency virus (HIV) and suboptimal response to hepatitis B vaccination. Ann Intern Med 1988;109:101-5.
18. Mannucci PM, Zanetti AR, Gringeri A et al. Long-term immunogenicity of a plasma-derived hepatitis B vaccine in HIV seropositive and HIV seronegative hemophiliacs. Arch Intern Med 1989;149:1333-7.
19. Loke RH, Murray-Lyon IM, Coleman JC et al. Diminished response to recombinant hepatitis B vaccine in homosexual men with HIV antibody: an indicator of poor prognosis. J Med Virol 1990;31:109-11.
20. Keet IP, van Doornum G, Safary A et al. InsuC cient response to hepatitis B vaccination in HIV-positive homosexual men. AIDS 1992;6:509-10.
21. Lugoboni F, Migliozzi S, Mezzelani P et al. Progressive decrease of hepatitis B in a cohort of drug users followed over a period of 15 years: the impact of anti-HBV vaccination. Scand J Infect Dis 2004;36:131-3.
22. Stevens CE, Beasley RP, Tsui J et al. Vertical transmission of hepatitis B antigen in Taiwan. N Engl J Med 1975;292:771-4.
23. Chen DS, Sung JL. Hepatitis B virus infection and chronic liver disease in Taiwan. Acta Hepatogastroenterol (Stuttg) 1978;25:423-30.
24. Chen DS, Hsu NH, Sung JL et al. A mass vaccination program in Taiwan against hepatitis B virus infection in infants of hepatitis B surface antigen-carrier mothers. JAMA 1987;257:2597-630.
25. Ni YH, Huang LM, hCang MH et al. Two decades of universal hepatitis B vaccination in Taiwan: impact and implication for future strategies. Gastroenterology 2007;132:1287-93.
26. Hsu HY, Chang MH, Chen DS et al. Baseline seroepidemiology of hepatitis B virus infection in children in Taipei, 1984: a study just before mass hepatitis B vaccination program in Taiwan. J Med Virol 1986;18:301-7.
27. Tsen YJ, Chang MH, Hsu HY et al. Seroprevalence of hepatitis B virus infection in children in Taipei, 1989: I ve years aD er a mass hepatitis B vaccination program. J Med Virol 1991;34:96-9.
28. Chen HL, Chang MH, Ni YH et al. Seroepidemiology of hepatitis B virus infection in children: ten years of mass vaccination in Taiwan. JAMA 1996;276:906-8.
29. Ni YH, Chang MH, Huang LM et al. Hepatitis B virus infection in children and adolescents in a hyperendemic area: 15 years aD er mass hepatitis B vaccination. Ann Intern Med 2001;135:796-800.
30. Lin YC, Chang MH, Ni YH et al. Long-term immunogenicity and eC cacy of universal hepatitis B virus vaccination in Taiwan. J Infect Dis 2003;187:134-8.
31. Lu SN, Chen CH, Chen TM et al. Hepatitis B virus infection in adolescents in a rural township 15 years subsequent to mass hepatitis B vaccination in Taiwan. V accine 2006;24:759-65.
32. Hsu HM, Lee SC, Wang MC et al. EC cacy of a mass hepatitis B immunization program aD er switching to recombinant hepatitis B vaccine: a population-based study in Taiwan. Vaccine 2001;19:2825-9.
33. Center for Disease Control DoH, Taiwan, R.O.C HIV/AIDS Reports. 31 December 2007 (cited 29 February 2008); Available from: http://www.cdc.gov.tw/ sp.asp?xdurl=disease/disease-content.asp&id=798&mp=1&ctnode=1498#7.
34. Yang CH, Huang YF, Hsiao CF et al. Trends of mortality and causes of death among HIV-infected patients in Taiwan, 1984-2005. HIV Med 2008;9:535-43.
35. Tassopoulos NC, Papaevangelou GJ, Sjogren MH et al. Natural history of acute hepatitis B surface antigen-positive hepatitis in Greek adults. Gastroenterology 1987;92:1844-50.
36. Sulkowski MS, E omas DL, Chaisson RE et al. Hepatotoxicity associated with antiretroviral therapy in adults infected with human immunodeficiency virus and the role of hepatitis C or B virus infection. JAMA 2000;283:74-80.
37. Thio CL, Seaberg EC, Skolasky R Jr et al. HIV-1, hepatitis B virus, and risk of liver-related mortality in the Multicenter Cohort Study (MACS). Lancet 2002;360:1921-6.